Attached files
| file | filename |
|---|---|
| 10-K - 10-K - Vyant Bio, Inc. | cgix-20191231x10xk.htm |
| EX-32.2 - EXHIBIT 32.2 - Vyant Bio, Inc. | a201910-kex322.htm |
| EX-32.1 - EXHIBIT 32.1 - Vyant Bio, Inc. | a201910-kex321.htm |
| EX-31.2 - EXHIBIT 31.2 - Vyant Bio, Inc. | a201910-kex312.htm |
| EX-31.1 - EXHIBIT 31.1 - Vyant Bio, Inc. | a201910-kex311.htm |
| EX-23.1 - EXHIBIT 23.1 - Vyant Bio, Inc. | a201910-kex231.htm |
| EX-4.14 - EXHIBIT 4.14 - Vyant Bio, Inc. | exh414descriptionofsecurit.htm |
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-191520, 333-191521, 333-196198, 333-205903 and 333-214599) and on Form S-3 (No. 333-218229) and on Form S-1 (No. 333-215284) of Cancer Genetics, Inc. of our report dated April 15, 2019, relating to the consolidated financial statements of Cancer Genetics, Inc. and Subsidiaries appearing in the Annual Report on Form 10-K of Cancer Genetics, Inc. for the year ended December 31, 2018.
/s/ RSM US LLP
New York, New York
May 29, 2020